Vonjo and Pain in extremity - a phase IV clinical study of FDA data

Summary:

Pain in extremity is reported as a side effect among people who take Vonjo (pacritinib citrate), especially for people who are male, 60+ old, also take Vitamin D3, and have Primary myelofibrosis.

The phase IV clinical study analyzes which people have Pain in extremity when taking Vonjo. It is created by eHealthMe based on reports of 1,939 people who have side effects when taking Vonjo from the FDA, and is updated regularly.

What is Vonjo?

Vonjo has active ingredients of pacritinib citrate. eHealthMe is studying from 1,939 Vonjo users. Check the latest studies of Vonjo.

What is Pain in extremity?

Pain in extremity is found to be associated with 3,222 drugs and 4,298 conditions by eHealthMe. Check the latest studies of Pain in extremity.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

1,939 people reported to have side effects when taking Vonjo.
Among them, 25 people (1.29%) have Pain in extremity.

Among these 25 people:

What is the gender of people who have Pain in extremity when taking Vonjo? *

female: 0.0 %
male: 100 %

What is the age of people who have Pain in extremity when taking Vonjo? *

What are other drugs people take besides Vonjo? *

What are other side effects people have besides Pain in extremity? *

Fatigue (feeling of tiredness): 6 people, 24.00%
Pain: 6 people, 24.00%
Malaise (a feeling of general discomfort or uneasiness): 5 people, 20.00%
Back Pain: 5 people, 20.00%
Feeling Abnormal: 5 people, 20.00%
Eating Disorder: 4 people, 16.00%
Nausea (feeling of having an urge to vomit): 4 people, 16.00%
Joint Pain: 4 people, 16.00%
Diarrhea: 4 people, 16.00%
Weight Decreased: 4 people, 16.00%

What are the existing conditions these people have? *

Primary Myelofibrosis (primary disorder of the bone marrow): 12 people, 48.00%
Essential Thrombocythaemia (chronic blood cancer): 6 people, 24.00%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 1 person, 4.00%
Pain: 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Vonjo and have Pain in extremity?

- Check whether Pain in extremity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vonjo:

Vonjo (1,939 reports)

Pain in extremity treatments and more:

Pain in extremity (376,792 reports)

Browse all side effects of Vonjo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pain in extremity:

Pain in extremity (3,222 drugs)

Browse all the conditions that are associated with Pain in extremity:

Pain in extremity (4,298 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pacritinib citrate (the active ingredients of Vonjo) and Vonjo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.